Mostafa Vaghari‐Tabari

1.1k total citations
27 papers, 840 citations indexed

About

Mostafa Vaghari‐Tabari is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Mostafa Vaghari‐Tabari has authored 27 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Mostafa Vaghari‐Tabari's work include Inflammatory Bowel Disease (10 papers), MicroRNA in disease regulation (7 papers) and Microscopic Colitis (4 papers). Mostafa Vaghari‐Tabari is often cited by papers focused on Inflammatory Bowel Disease (10 papers), MicroRNA in disease regulation (7 papers) and Microscopic Colitis (4 papers). Mostafa Vaghari‐Tabari collaborates with scholars based in Iran, United Kingdom and Australia. Mostafa Vaghari‐Tabari's co-authors include Durdi Qujeq, Soheila Moein, Bahman Yousefi, Zatollah Asemi, Fatemeh Sadeghsoltani, Forough Alemi, Mehrdad Kashifard, Faezeh Malakoti, Gordon A. Ferns and Maryam Majidinia and has published in prestigious journals such as Biochemical Pharmacology, Critical Reviews in Food Science and Nutrition and Life Sciences.

In The Last Decade

Mostafa Vaghari‐Tabari

27 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mostafa Vaghari‐Tabari Iran 16 369 186 171 106 105 27 840
Xueming Zhang China 20 633 1.7× 153 0.8× 168 1.0× 67 0.6× 87 0.8× 92 1.3k
Maria Principia Scavo Italy 19 394 1.1× 96 0.5× 182 1.1× 49 0.5× 136 1.3× 57 877
Qingqing Zhang China 16 490 1.3× 97 0.5× 170 1.0× 50 0.5× 79 0.8× 38 1.0k
Anna Han United States 14 532 1.4× 68 0.4× 118 0.7× 66 0.6× 73 0.7× 41 870
Isabella Gigante Italy 15 298 0.8× 71 0.4× 100 0.6× 66 0.6× 55 0.5× 32 775
Dan Huang China 18 753 2.0× 127 0.7× 228 1.3× 48 0.5× 89 0.8× 56 1.3k
Xiaoqing Yi China 18 508 1.4× 72 0.4× 219 1.3× 37 0.3× 119 1.1× 45 913
Ni Shi United States 19 348 0.9× 85 0.5× 100 0.6× 84 0.8× 66 0.6× 45 920
Zizhen Gong China 13 557 1.5× 110 0.6× 68 0.4× 82 0.8× 169 1.6× 32 1.0k

Countries citing papers authored by Mostafa Vaghari‐Tabari

Since Specialization
Citations

This map shows the geographic impact of Mostafa Vaghari‐Tabari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mostafa Vaghari‐Tabari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mostafa Vaghari‐Tabari more than expected).

Fields of papers citing papers by Mostafa Vaghari‐Tabari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mostafa Vaghari‐Tabari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mostafa Vaghari‐Tabari. The network helps show where Mostafa Vaghari‐Tabari may publish in the future.

Co-authorship network of co-authors of Mostafa Vaghari‐Tabari

This figure shows the co-authorship network connecting the top 25 collaborators of Mostafa Vaghari‐Tabari. A scholar is included among the top collaborators of Mostafa Vaghari‐Tabari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mostafa Vaghari‐Tabari. Mostafa Vaghari‐Tabari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaghari‐Tabari, Mostafa, Durdi Qujeq, & Mohammad Sadegh Hashemzadeh. (2024). Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers. Biomedicine & Pharmacotherapy. 179. 117368–117368. 4 indexed citations
2.
Vaghari‐Tabari, Mostafa, et al.. (2023). Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?. Biological Trace Element Research. 202(5). 1878–1900. 12 indexed citations
3.
Vaghari‐Tabari, Mostafa, Soheila Moein, Durdi Qujeq, et al.. (2022). Melatonin and inflammatory bowel disease: From basic mechanisms to clinical application. Biochimie. 209. 20–36. 12 indexed citations
4.
Vaghari‐Tabari, Mostafa, et al.. (2022). MicroRNAs and Periodontal Disease: Helpful Therapeutic Targets?. Advanced Pharmaceutical Bulletin. 13(3). 423–434. 1 indexed citations
5.
Vaghari‐Tabari, Mostafa, Niloufar Targhazeh, Soheila Moein, et al.. (2022). From inflammatory bowel disease to colorectal cancer: what’s the role of miRNAs?. Cancer Cell International. 22(1). 146–146. 22 indexed citations
6.
Ferns, Gordon A., et al.. (2022). MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity. Biochemical Pharmacology. 201. 115094–115094. 26 indexed citations
7.
Vaghari‐Tabari, Mostafa, Fatemeh Sadeghsoltani, Faezeh Malakoti, et al.. (2022). CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer. Cellular & Molecular Biology Letters. 27(1). 49–49. 88 indexed citations
8.
Yan, Lei, Mostafa Vaghari‐Tabari, Faezeh Malakoti, et al.. (2022). Quercetin: an effective polyphenol in alleviating diabetes and diabetic complications. Critical Reviews in Food Science and Nutrition. 63(28). 9163–9186. 89 indexed citations
9.
Sadeghsoltani, Fatemeh, et al.. (2021). Zinc and Respiratory Viral Infections: Important Trace Element in Anti-viral Response and Immune Regulation. Biological Trace Element Research. 200(6). 2556–2571. 33 indexed citations
10.
Jafari-Gharabaghlou, Davoud, Mostafa Vaghari‐Tabari, Hajar Oghbaei, et al.. (2021). Role of adipokines in embryo implantation. Endocrine Connections. 10(11). R267–R278. 8 indexed citations
11.
Asemi, Zatollah, et al.. (2021). Role of exosomal miRNA in chemotherapy resistance of Colorectal cancer: A systematic review. Chemical Biology & Drug Design. 101(5). 1096–1112. 15 indexed citations
12.
Khaki‐Khatibi, Fatemeh, Durdi Qujeq, Mehrdad Kashifard, et al.. (2020). Calprotectin in inflammatory bowel disease. Clinica Chimica Acta. 510. 556–565. 83 indexed citations
13.
Vaghari‐Tabari, Mostafa, et al.. (2020). Sensitivity and specificity of mean platelet volume as a laboratory marker for irritable bowel syndrome: Can it be added to Rome criteria?. African Journal of Laboratory Medicine. 9(1). 1001–1001. 4 indexed citations
14.
Vaghari‐Tabari, Mostafa, Davoud Jafari-Gharabaghlou, Fatemeh Sadeghsoltani, et al.. (2020). Zinc and Selenium in Inflammatory Bowel Disease: Trace Elements with Key Roles?. Biological Trace Element Research. 199(9). 3190–3204. 57 indexed citations
15.
16.
Vaghari‐Tabari, Mostafa, Maryam Majidinia, Soheila Moein, et al.. (2020). MicroRNAs and colorectal cancer chemoresistance: New solution for old problem. Life Sciences. 259. 118255–118255. 49 indexed citations
17.
Mohammadzadeh, Iraj, et al.. (2020). Association of serum 25-OH vitamin D3 with serum IgE and the Pediatric Asthma Severity Score in patients with pediatric asthma. Allergy and Asthma Proceedings. 41(2). 126–133. 15 indexed citations
18.
19.
Vaghari‐Tabari, Mostafa, Soheila Moein, Durdi Qujeq, Mehrdad Kashifard, & Karimollah Hajian‐Tilaki. (2017). Positive Correlation of Fecal Calprotectin With Serum Antioxidant Enzymes in Patients With Inflammatory Bowel Disease: Accidental Numerical Correlation or a New Finding?. The American Journal of the Medical Sciences. 355(5). 449–455. 23 indexed citations
20.
Vaghari‐Tabari, Mostafa, et al.. (2017). Evaluation of the Potential Antioxidant Role of High-Density Lipoprotein-Cholesterol (HDL-C) in Patients with Ulcerative Colitis. In Press(In Press). 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xueming Zhang Breakdown of academic impact, for papers by Maria Principia Scavo Breakdown of academic impact, for papers by Qingqing Zhang Breakdown of academic impact, for papers by Anna Han Breakdown of academic impact, for papers by Isabella Gigante Breakdown of academic impact, for papers by Dan Huang Breakdown of academic impact, for papers by Xiaoqing Yi Breakdown of academic impact, for papers by Ni Shi Breakdown of academic impact, for papers by Zizhen Gong
Rankless by CCL
2026